GL1X · GenesisL1 explorer

MolNFT v1 · #138374 · protein

USP7 in complex with CPD2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4- oxadiazol-5-YL)PHENOL)

5WHC · Ubiquitin carboxyl-terminal hydrolase 7: “USP7 in complex with CPD2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4- oxadiazol-5-YL)PHENOL)”. X-ray diffraction, 1 ligand (AJJ), 11 pockets (best druggability 0.65). MolNFT v1 #138374 on…

PDB
5WHC
Type
protein
Length
676 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase 7
EC
3.4.19.12
UniProt
Q93009
Ligands
AJJ
Pockets
11 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BUbiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12)protein33833% helix, 27% strandQ93009

Ligands and binding sites

  • AJJ · 4-[3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl]phenol · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11480.650.8726GOL
24390.640.7745GOL
32050.540.7935empty
4620.470.8413AJJ
51470.440.7522empty

Interfaces

1 interface between chains.

  • A–B · 882 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 5WHC · USP7 in complex with Cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl)phenol) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.